Nine patents currently held, every record listed here
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Aug 2032. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Aug 2032
Next term end
9
Patent families
When these terms end
Each bar runs from grant to computed term end. 2017 to 2043.
US 11,160,840
Composition for Improvement of Muscle Function Containing 3,5-Dicaffeoylquinic Acid or Chrysanthemum Extract
Nov 30, 2037
US 11,779,626
Composition for Enhancing Immunity or Preventing or Treating Neurodegenerative Diseases by Using Goji Berries, Mulberries and Jujubes
Apr 27, 2038
US 11,980,649
Composition for the Prevention or Treatment of Respiratory Diseases Caused by Fine Dust Comprising Agastache Rugosa and Licorice Extract
May 21, 2040
US 11,628,195
Method for Preparing Iridoid-Rich Noni Fruit Extract or Fraction Thereof, Method for Preparing Immune-Enhancing Active Material-Rich Noni Fruit Extract or Fraction Thereof and Use of Noni Fruit Extract or Fraction Thereof
Jun 2, 2040
US 11,382,336
Emulsified Oil Composition for Suppressing Off-Taste and Off-Flavor Including Oil Containing Polyunsaturated Fatty Acids, Food Containing the Same, and Methods for Preparing the Same
Jun 9, 2040
US 12,734,206
Composition for Hangover Relief Comprising Noni Fruit Extract or Fraction Thereof and Use Thereof
Jan 17, 2043
202220272032203720422043
Every computed term in this portfolio is shown above.Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Nov 2037 · High confidence
Also notable
Ends Jun 2040 · High confidence
Also notable
Ends Jan 2043 · High confidence
Composition for Improvement of Muscle Function Containing 3,5-Dicaffeoylquinic Acid or Chrysanthemum Extract
US 11,160,840
The earliest of the three still in force, granted 2021 and renewed since. Its term ends first, in 2037.
Method for Preparing Iridoid-Rich Noni Fruit Extract or Fraction Thereof, Method for Preparing Immune-Enhancing Active Material-Rich Noni Fruit Extract or Fraction Thereof and Use of Noni Fruit Extract or Fraction Thereof
US 11,628,195
Granted 2023. Computed term ends 2040.
Composition for Hangover Relief Comprising Noni Fruit Extract or Fraction Thereof and Use Thereof
US 12,734,206
Granted 2026. Too new for citation comparison; protection runs to 2043.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 10, 2027The maintenance fee for Composition for Enhancing Immunity or Preventing or Treating Neurodegenerative Diseases by Using Goji Berries, Mulberries and Jujubes (US 11,779,626) comes due Apr 10, 2027. Unpaid by Oct 12, 2027, it lapses early.
- 1 fee due Nov 14, 2027The maintenance fee for Composition for the Prevention or Treatment of Respiratory Diseases Caused by Fine Dust Comprising Agastache Rugosa and Licorice Extract (US 11,980,649) comes due Nov 14, 2027. Unpaid by May 15, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 20, 2026
What they patent
The 5 largest of its 9 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Showing 1 to 9 of 9
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US D793,239 | Container In force · High confidence | In force | High confidence | |
| US 10,722,548 | Method of Preparing Lyophilizate of Taheebo Alcohol Extract In force · High confidence | In force | High confidence | |
| US 11,160,840 | Composition for Improvement of Muscle Function Containing 3,5-Dicaffeoylquinic Acid or Chrysanthemum Extract In force · High confidence | In force | High confidence | |
| US 10,682,384 | Composition Comprising Natural Complex Extract as Active Ingredient In force · High confidence | In force | High confidence | |
| US 11,779,626 | Composition for Enhancing Immunity or Preventing or Treating Neurodegenerative Diseases by Using Goji Berries, Mulberries and Jujubes In force · Medium confidence | In force | Medium confidence | |
| US 11,980,649 | Composition for the Prevention or Treatment of Respiratory Diseases Caused by Fine Dust Comprising Agastache Rugosa and Licorice Extract In force · High confidence | In force | High confidence | |
| US 11,628,195 | Method for Preparing Iridoid-Rich Noni Fruit Extract or Fraction Thereof, Method for Preparing Immune-Enhancing Active Material-Rich Noni Fruit Extract or Fraction Thereof and Use of Noni Fruit Extract or Fraction Thereof In force · High confidence | In force | High confidence | |
| US 11,382,336 | Emulsified Oil Composition for Suppressing Off-Taste and Off-Flavor Including Oil Containing Polyunsaturated Fatty Acids, Food Containing the Same, and Methods for Preparing the Same In force · High confidence | In force | High confidence | |
| US 12,734,206 | Composition for Hangover Relief Comprising Noni Fruit Extract or Fraction Thereof and Use Thereof In force · High confidence | In force | High confidence |
Also on record, not counted in the 9: 7 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.